Delivery Order SPE2DB22D2007-SPE2DB25FJ4TH
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,771.04 to AmerisourceBergen Drug Corp for 30 units of Orgovyx 120 mg tablets, a pharmaceutical product used in hormone-based cancer treatment. Issued on July 21, 2025, with an ultimate completion date of August 11, 2025, this firm fixed-price delivery order represents a routine pharmaceutical supply transaction under a competitive, non-set-aside procurement. The work will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a $1,385.52 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Orgovyx 120 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 20, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $5,542.08 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets (30-count unit of use packaging) on July 21, 2025, with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $1,385.52, is scheduled for completion by August 14, 2025, with performance taking place at the contractor's Conshohocken, Pennsylvania location. The contract was competitively awarded without set-aside provisions, reflecting AmerisourceBergen's capability to meet federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 30 tablets of Orgovyx 120 mg with a firm fixed price ceiling value of $1,385.52. This non-set-aside delivery order was awarded on July 31, 2025, and carries an ultimate completion date of August 21, 2025. The contract specifies performance at AmerisourceBergen's Conshohocken, Pennsylvania location, where the company maintains its corporate office and serves as a major pharmaceutical distributor for federal...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order valued at $2,771.04 by the Defense Logistics Agency for 30 tablets of Orgovyx 120 mg, with an ultimate completion date of September 9, 2025. This is a non-set-aside, competitively awarded contract representing a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The company...
- The Defense Logistics Agency awarded a delivery order valued at $1,385.52 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets (30-count units) on July 22, 2025, with an ultimate completion date of August 12, 2025. This non-competitive, firm fixed-price delivery order was issued without a set-aside designation and is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Orgovyx 120 mg tablets (quantity: 30 units) under a firm fixed price contract. The award, valued at $16,626.24, has an ultimate completion date of September 12, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This competitively awarded, non-set-aside delivery order represents a single procurement action against AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,385.52 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets (30-count units) on August 27, 2025, with an ultimate completion date of September 18, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's facility in...
- This delivery order, awarded on July 30, 2025, to AmerisourceBergen Drug Corp supplies 30 tablets of Orgovyx 120 mg under a firm fixed price contract valued at $2,771.04. The award is a non-set-aside, competitively awarded delivery order with an ultimate completion date of August 20, 2025, and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The order is funded through the Defense agency's Medical Supply Chain and represents a child contract under a...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ4THDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,385.52 to AmerisourceBergen Drug Corp for 30 units of Orgovyx 120 mg tablets, a pharmaceutical product used in hormone therapy. This competitively awarded, firm fixed-price contract was issued on September 8, 2025, with an ultimate completion date of September 29, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this procurement. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical supply mechanism enabling AmerisourceBergen to deliver a broad range of medications, vaccines, and medical supplies to support military healthcare programs and other federal healthcare systems worldwide, including the Defense Health Agency and U.S. Coast Guard. The company's extensive federal contract portfolio demonstrates its established capability to meet competitive procurement requirements across diverse pharmaceutical and medical supply categories.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 9/8/25 |